Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer

Clinical trial NCT00801242 · COMPLETED

Trial details

NCT number: NCT00801242
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2008-12-01
Primary completion: 2012-06-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.